Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial-Reference-Cited by-同舟云学术

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

Published:2010-07 Issue:9737 Volume:376 Page:235-244
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Tutt Andrew,Robson Mark,Garber Judy E,Domchek Susan M,Audeh M William,Weitzel Jeffrey N,Friedlander Michael,Arun Banu,Loman Niklas,Schmutzler Rita K,Wardley Andrew,Mitchell Gillian,Earl Helena,Wickens Mark,Carmichael James

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. Epidemiology of breast cancer. Findings from the nurses' health study;Colditz;Cancer,1993

2. Breast cancer and hormone-replacement therapy in the Million Women Study;Lancet,2003

3. Genome-wide association study identifies novel breast cancer susceptibility loci;Easton;Nature,2007

4. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1;Miki;Science,1994

5. Identification of the breast cancer susceptibility gene BRCA2;Wooster;Nature,1995

Cited by 1532 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circadian rhythms and breast cancer: from molecular level to therapeutic advancements;Journal of Cancer Research and Clinical Oncology;2024-09-12

2. Talazoparib for the treatment of prostate cancer;Expert Opinion on Pharmacotherapy;2024-08-29

3. Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer;Current Treatment Options in Oncology;2024-08-15

4. CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos;International Journal of Molecular Sciences;2024-08-06

5. Personalized treatment using predictive biomarkers in solid organ malignancies: A review;Tumori Journal;2024-08-02